xylazine has been researched along with Kidney Diseases in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verney, C | 1 |
| Legouis, D | 1 |
| Placier, S | 1 |
| Migeon, T | 1 |
| Bonnin, P | 1 |
| Buob, D | 1 |
| Hadchouel, J | 1 |
| Galichon, P | 1 |
1 other study available for xylazine and Kidney Diseases
| Article | Year |
|---|---|
Anaesthesia-Induced Transcriptomic Changes in the Context of Renal Ischemia Uncovered by the Use of a Novel Clamping Device.
Topics: Anesthesia; Animals; Disease Models, Animal; Ketamine; Kidney; Kidney Diseases; Male; Mice; Reperfus | 2021 |